Invasive Species Corporation (a Delaware Public Benefit Corp) develops, discovers and markets bio-based solutions to control invasive species across water, forestry and agriculture. Its current commercial product Zequanox® targets invasive zebra and quagga mussels, and it is developing Piscamycin™ for invasive carp; the company is also in the discovery phase on a microbial natural product (bioherbicide) for problematic weeds. ISC reports it is currently selling Zequanox® and advancing Piscamycin™ while pursuing additional product lines. The company recently received a $388,000 grant from the Washington State Department of Agriculture to find a microbial solution for burrowing shrimp that harm oyster beds. ISC says it will use new financing to improve and expand product lines and to continue developing stronger customer relationships. The firm positions its mission around regenerating ecological biodiversity and deploying natural, sustainable control solutions to address invasive-species-driven biodiversity loss and climate impacts.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Nov 2023